ResMed (LTS:0KW4) Institutional Ownership : 38.53% (As of May. 21, 2024)

View and export this data going back to 2018. Start your Free Trial

What is ResMed Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ResMed's institutional ownership is 38.53%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ResMed's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ResMed's Float Percentage Of Total Shares Outstanding is 87.65%.

ResMed Institutional Ownership Historical Data

The historical data trend for ResMed's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Institutional Ownership Chart

ResMed Historical Data

The historical data trend for ResMed can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	47.32	45.85	41.25	37.72	37.63	37.97	38.16	37.98	38.63	38.53

ResMed Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

ResMed (LTS:0KW4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (LTS:0KW4) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

RSMDF:USA RMD:USA RMEA:Germany R1MD34:Brazil RMD:Australia

Address

9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123

Website

https://www.resmed.com

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (LTS:0KW4) Headlines

No Headlines